This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558479310 units of Tresiba FlexTouch insulin pens. The $2,376.48 firm fixed-price delivery order has a completion date of September 16, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of Tresiba FlexTouch insulin pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,484.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. The contract is not designated as a set-aside and represents a direct procurement under AmerisourceBergen's existing Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba Flextouch insulin pens. The $7,699.35 firm fixed price contract has an ultimate completion date of August 21, 2024. This order is part of a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba Flextouch 200 unit/mL 3mL insulin delivery pens. The single-award Delivery Order, valued at $15,711.19, has a firm fixed price and was not designated with a set-aside requirement. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,162.44 firm fixed-price contract is for the delivery of Tresiba FlexTouch 200 unit/ml 3ml insulin pens, with a period of performance through July 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Tresiba FlexTouch insulin therapy products to the Defense Logistics Agency (DLA) Troop Support Medical, a major acquisition center within the Department of Defense. The $2,269 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, to supply 200 unit/mL, 3 mL insulin pens. The award is a delivery order issued under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,781.95 award is for a delivery order to supply Tresiba Flextouch insulin pens, a specialty medication. The contract is a firm fixed-price arrangement with a performance period ending on August 9, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Tresiba Flextouch 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The award, valued at $2,713.82, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2023. The contract was awarded on November 6, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,873.90 firm-fixed-price contract is for the delivery of Tresiba FlexTouch insulin pens. The award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. The award has a ceiling value of $3,602.79 and is a Firm Fixed Price Delivery Order contract with a completion date of September 24, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to support various...